4//SEC Filing
Menawat Arun Swarup 4
Accession 0001171843-25-003336
CIK 0001628808other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 1:56 PM ET
Size
7.7 KB
Accession
0001171843-25-003336
Insider Transaction Report
Form 4
Menawat Arun Swarup
DirectorCEO
Transactions
- Purchase
Common Shares
2025-05-15$4.33/sh+10,003$43,263→ 575,062 total - Purchase
Common Shares
2025-05-16$4.73/sh+12,027$56,888→ 587,089 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.30 to $4.35, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The reporting person undertakes to provide to Profound Medical Corp., any security holder of Profound Medical Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.
Documents
Issuer
Profound Medical Corp.
CIK 0001628808
Entity typeother
Related Parties
1- filerCIK 0001685893
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 1:56 PM ET
- Size
- 7.7 KB